CPSC Posts Product Safety Warnings to its Web Site
CPSC Warns Consumers to Immediately Stop Using Mad Rabbit "RELIEVE" Lidocaine Numbing Cream Due to Risk of Serious Injury or Death to Young Children from Poisoning; Violates the Mandatory Standard for Child-Resistant Packaging (25-386)
CPSC Warns Consumers to Immediately Stop Using Mad Rabbit "RELIEVE" Lidocaine Numbing Cream Due to Risk of Serious Injury or Death to Young Children from Poisoning; Violates the Mandatory Standard for Child-Resistant Packaging | CPSC.gov
About the
The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risk of injury associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product-related incidents cost the nation more than
Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.
For lifesaving information:
- Visit CPSC.gov.
- Sign up to receive our e-mail alerts.
- Follow us on Facebook, Instagram, X, BlueSky, Threads, LinkedIn and Truth Social.
- Report a dangerous product or a product-related injury on www.SaferProducts.gov.
- Call CPSC's Hotline at 800-638-2772 (TTY 800-638-8270).
- Contact a media specialist.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cpsc-posts-product-safety-warnings-to-its-web-site-302508126.html
SOURCE U.S. Consumer Product Safety Commission
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Twitch Phenom Cinna Declares for Bang Energy During Record-Breaking Subathon Attempt
- 6 Best Crypto Presales as AlphaPepe Turns Bitcoin’s Two-Week Low Into Small-Bet FOMO
- BCAS Calls for National Commission on the Legacy of Slavery and Anti-Black Racism in Canada
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share